---, Nov. 19 (UPI) -- Gene profile technology may help determine prognosis of patients with advanced ovarian cancer, over-expression of a newly identified protein diminishes the activity of tumor-suppressor p53, and other genetic research news.
Researchers zeroed in on the PASG gene after finding mutated forms occur in acute leukemias, patients whose lung cancers contain a malfunctioning protein respond well to the drug Iressa, and other genetic news.
Since 1907, United Press International (UPI) has been a leading provider of critical information to media outlets, businesses, governments and researchers worldwide. UPI is a global operation with offices in Beirut, Hong Kong, London, Santiago, Seoul and Tokyo. Our headquarters is located in downtown Washington, DC, surrounded by major international policy-making governmental and non-governmental organizations.
UPI licenses content directly to print outlets, online media and institutions of all types. In addition, UPI's distribution partners provide our content to thousands of businesses, policy groups and academic institutions worldwide. Our audience consists of millions of decision-makers who depend on UPI's insightful and analytical stories to make better business or policy decisions.
In the year of our 107th anniversary, our company strives to continue being a leading and trusted source for news, analysis and insight for readers around the world.